{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:09:33Z","timestamp":1787242173688,"version":"build-2736575974"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"crossref","award":["252215"],"award-info":[{"award-number":["252215"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"crossref","award":["281300"],"award-info":[{"award-number":["281300"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"crossref"}]},{"name":"University of Helsinki Research Funds"},{"name":"Biocentrum Helsinki"},{"name":"European Research Council","award":["310892"],"award-info":[{"award-number":["310892"]}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","award":["PEst-C\/SAU\/LA0002\/2013"],"award-info":[{"award-number":["PEst-C\/SAU\/LA0002\/2013"]}]},{"name":"National Strategic Reference Framework","award":["SAESCTN-PIIC&DT\/2011"],"award-info":[{"award-number":["SAESCTN-PIIC&DT\/2011"]}]},{"DOI":"10.13039\/501100003125","name":"Finnish Cultural Foundation","doi-asserted-by":"crossref","award":["00150869"],"award-info":[{"award-number":["00150869"]}],"id":[{"id":"10.13039\/501100003125","id-type":"DOI","asserted-by":"crossref"}]},{"name":"FCT","award":["SFRH\/BD\/87016\/2012"],"award-info":[{"award-number":["SFRH\/BD\/87016\/2012"]}]},{"name":"FCT","award":["SFRH\/BD\/90404\/2012"],"award-info":[{"award-number":["SFRH\/BD\/90404\/2012"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.jconrel.2016.04.024","type":"journal-article","created":{"date-parts":[[2016,4,16]],"date-time":"2016-04-16T15:53:06Z","timestamp":1460821986000},"page":"113-119","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":64,"special_numbering":"C","title":["Oral hypoglycaemic effect of GLP-1 and DPP4 inhibitor based nanocomposites in a diabetic animal model"],"prefix":"10.1016","volume":"232","author":[{"given":"Neha","family":"Shrestha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisca","family":"Ara\u00fajo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad-Ali","family":"Shahbazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ermei","family":"M\u00e4kil\u00e4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Jo\u00e3o","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikko","family":"Airavaara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esko I.","family":"Kauppinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janne","family":"Raula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jarno","family":"Salonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jouni","family":"Hirvonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Sarmento","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7850-6309","authenticated-orcid":false,"given":"H\u00e9lder A.","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2016.04.024_bb0005","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.drudis.2013.05.011","article-title":"Future directions for peptide therapeutics development","volume":"18","author":"Kaspar","year":"2013","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jconrel.2016.04.024_bb0010","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/nrd2399","article-title":"Protein therapeutics: a summary and pharmacological classification","volume":"7","author":"Leader","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2016.04.024_bb0015","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nrd1695","article-title":"Protein drug stability: a formulation challenge","volume":"4","author":"Frokjaer","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2016.04.024_bb0020","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v20.i23.30","article-title":"Emerging trends in oral delivery of peptide and protein drugs","volume":"20","author":"Mahato","year":"2003","journal-title":"Crit. Rev. Ther. Drug Carrier Syst."},{"key":"10.1016\/j.jconrel.2016.04.024_bb0025","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.drudis.2006.08.005","article-title":"Is the oral route possible for peptide and protein drug delivery","volume":"11","author":"Morishita","year":"2006","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jconrel.2016.04.024_bb0030","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1177\/193229681300700228","article-title":"Oral insulin delivery: how far are we?","volume":"7","author":"Fonte","year":"2013","journal-title":"J. Diabetes Sci. Technol."},{"key":"10.1016\/j.jconrel.2016.04.024_bb0035","doi-asserted-by":"crossref","first-page":"28","DOI":"10.2174\/138920013804545133","article-title":"Improving oral absorption via drug-loaded nanocarriers: absorption mechanisms, intestinal models and rational fabrication","volume":"14","author":"Shahbazi","year":"2013","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.jconrel.2016.04.024_bb0040","article-title":"Enhanced oral bioavailability of insulin using PLGA nanoparticles co-modified with cell-penetrating peptides and engrailed secretion peptide (Sec)","volume":"1-12","author":"Zhu","year":"2015","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2016.04.024_bb0045","doi-asserted-by":"crossref","first-page":"9678","DOI":"10.1016\/j.biomaterials.2013.08.048","article-title":"Intestinal mucosa permeability following oral insulin delivery using core shell corona nanolipoparticles","volume":"34","author":"Li","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2016.04.024_bb0050","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1007\/s001250051529","article-title":"Oral delivery of glucagon-like peptide-1 in a modified polymer preparation normalizes basal glycaemia in diabetic db\/db mice","volume":"43","author":"Joseph","year":"2000","journal-title":"Diabetologia"},{"key":"10.1016\/j.jconrel.2016.04.024_bb0055","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1021\/acsnano.5b00028","article-title":"Overcoming the diffusion barrier of mucus and absorption barrier of epithelium by self-assembled nanoparticles for oral delivery of insulin","volume":"9","author":"Shan","year":"2015","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2016.04.024_bb0060","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1002\/jps.20999","article-title":"Mesoporous silicon in drug delivery applications","volume":"97","author":"Salonen","year":"2008","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2016.04.024_bb0065","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1517\/17425247.4.2.101","article-title":"Mesoporous silicon: a platform for the delivery of therapeutics","volume":"4","author":"Prestidge","year":"2007","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2016.04.024_bb0070","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.biomaterials.2015.07.045","article-title":"Multistage pH-responsive mucoadhesive nanocarriers prepared by aerosol flow reactor technology: a controlled dual protein-drug delivery system","volume":"68","author":"Shrestha","year":"2015","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2016.04.024_bb0075","doi-asserted-by":"crossref","first-page":"8291","DOI":"10.1021\/acsnano.5b02762","article-title":"Microfluidic assembly of a multifunctional tailorable composite system designed for site specific combined oral delivery of peptide drugs","volume":"9","author":"Araujo","year":"2015","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2016.04.024_bb0080","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.jconrel.2012.03.017","article-title":"Chitosan-based drug nanocarriers: where do we stand?","volume":"161","author":"Garcia-Fuentes","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2016.04.024_bb0085","doi-asserted-by":"crossref","first-page":"8712","DOI":"10.1016\/j.biomaterials.2011.07.086","article-title":"Effects of chitosan-nanoparticle-mediated tight junction opening on the oral absorption of endotoxins","volume":"32","author":"Sonaje","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2016.04.024_bb0090","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1021\/mp200572t","article-title":"Opening of epithelial tight junctions and enhancement of paracellular permeation by chitosan: microscopic, ultrastructural, and computed-tomographic observations","volume":"9","author":"Sonaje","year":"2012","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2016.04.024_bb0095","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ijpharm.2004.07.003","article-title":"Influence of the solvent composition on the aerosol synthesis of pharmaceutical polymer nanoparticles","volume":"284","author":"Raula","year":"2004","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2016.04.024_bb0100","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1021\/bm500704e","article-title":"Polypeptide-based aerosol nanoparticles: self-assembly and control of conformation by solvent and thermal annealing","volume":"15","author":"Rahikkala","year":"2014","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2016.04.024_bb0105","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0939-6411(03)00005-5","article-title":"Aerosol flow reactor method for synthesis of drug nanoparticles","volume":"55","author":"Eerikainen","year":"2003","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2016.04.024_bb0110","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ijpharm.2013.01.026","article-title":"Gas-phase synthesis of solid state DNA nanoparticles stabilized by l-leucine","volume":"444","author":"Raula","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2016.04.024_bb0115","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.ijpharm.2012.11.036","article-title":"Coated particle assemblies for the concomitant pulmonary administration of budesonide and salbutamol sulphate","volume":"441","author":"Raula","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2016.04.024_bb0120","doi-asserted-by":"crossref","first-page":"8401","DOI":"10.1021\/ma301687b","article-title":"Thermally sensitive block copolymer particles prepared via aerosol flow reactor method: morphological characterization and behavior in water","volume":"45","author":"Nykanen","year":"2012","journal-title":"Macromolecules"},{"key":"10.1016\/j.jconrel.2016.04.024_bb0125","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0378-5173(03)00370-3","article-title":"Preparation of polymeric nanoparticles containing corticosteroid by a novel aerosol flow reactor method","volume":"263","author":"Eerikainen","year":"2003","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2016.04.024_bb0130","doi-asserted-by":"crossref","first-page":"609","DOI":"10.2174\/1389201015666140915150312","article-title":"Antihyperglycemic potential of incretins orally delivered via nano and microsystems and subsequent glucoregulatory effects","volume":"15","author":"Araujo","year":"2014","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.jconrel.2016.04.024_bb0135","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s11892-003-0079-9","article-title":"Gut peptides and type 2 diabetes mellitus treatment","volume":"3","author":"Ahren","year":"2003","journal-title":"Current Diabetes Reports"},{"key":"10.1016\/j.jconrel.2016.04.024_bb0140","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1016\/S0140-6736(06)69705-5","article-title":"The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes","volume":"368","author":"Drucker","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.jconrel.2016.04.024_bb0145","doi-asserted-by":"crossref","first-page":"4497","DOI":"10.1002\/adma.201400953","article-title":"Fabrication of a multifunctional nano-in-micro drug delivery platform by microfluidic templated encapsulation of porous silicon in polymer matrix","volume":"26","author":"Zhang","year":"2014","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2016.04.024_bb0150","article-title":"A prospective cancer chemo-immunotherapy approach mediated by synergistic CD326 targeted porous silicon nanovectors","volume":"1-17","author":"Shahbazi","year":"2014","journal-title":"Nano Res."},{"key":"10.1016\/j.jconrel.2016.04.024_bb0155","doi-asserted-by":"crossref","first-page":"H59","DOI":"10.1149\/1.1432679","article-title":"Thermal hydrosilylation of undecylenic acid with porous silicon","volume":"149","author":"Boukherroub","year":"2002","journal-title":"J. Electrochem. Soc."},{"key":"10.1016\/j.jconrel.2016.04.024_bb0160","doi-asserted-by":"crossref","first-page":"10847","DOI":"10.1039\/c0dt00936a","article-title":"Bioconjugate functionalization of thermally carbonized porous silicon using a radical coupling reaction","volume":"39","author":"Sciacca","year":"2010","journal-title":"Dalton Trans."},{"key":"10.1016\/j.jconrel.2016.04.024_bb0165","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/s11095-011-0611-6","article-title":"Mesoporous silicon (PSi) for sustained peptide delivery: effect of psi microparticle surface chemistry on peptide YY3-36 release","volume":"29","author":"Kovalainen","year":"2012","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2016.04.024_bb0170","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1081\/DDC-120027506","article-title":"Evaluation of hypromellose acetate succinate (HPMCAS) as a carrier in solid dispersions","volume":"30","author":"Tanno","year":"2004","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.jconrel.2016.04.024_bb0175","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3109\/02652040903059163","article-title":"Effects of pH-sensitive nanoparticles prepared with different polymers on the distribution, adhesion and transition of Rhodamine 6G in the gut of rats","volume":"27","author":"Wu","year":"2010","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.jconrel.2016.04.024_bb0180","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ejpb.2012.07.014","article-title":"pH-sensitive polymeric nanoparticles to improve oral bioavailability of peptide\/protein drugs and poorly water-soluble drugs","volume":"82","author":"Wang","year":"2012","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2016.04.024_bb0185","doi-asserted-by":"crossref","first-page":"5691","DOI":"10.1016\/j.biomaterials.2009.06.055","article-title":"Drug permeability and mucoadhesion properties of thiolated trimethyl chitosan nanoparticles in oral insulin delivery","volume":"30","author":"Yin","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2016.04.024_bb0190","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.ijpharm.2007.08.051","article-title":"Beneficial properties for insulin absorption using superporous hydrogel containing interpenetrating polymer network as oral delivery vehicles","volume":"350","author":"Yin","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2016.04.024_bb0195","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1258\/ebm.2012.011372","article-title":"Streptozotocin-nicotinamide-induced diabetes in the rat. Characteristics of the experimental model","volume":"237","author":"Szkudelski","year":"2012","journal-title":"Experimental Biology and Medicine (Maywood, N.J.)"},{"key":"10.1016\/j.jconrel.2016.04.024_bb0200","first-page":"408","article-title":"Streptozotocin-nicotinamide-induced rat model of type 2 diabetes (review)","volume":"101","author":"Ghasemi","year":"2014","journal-title":"Acta Vet. Hung."},{"key":"10.1016\/j.jconrel.2016.04.024_bb0205","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.sjbs.2014.03.001","article-title":"Purification and functional characterization of pancreatic insulin from camel (Camelus dromedarius)","volume":"21","author":"Elamin","year":"2014","journal-title":"Saudi J. Biol. Sci."},{"key":"10.1016\/j.jconrel.2016.04.024_bb0210","doi-asserted-by":"crossref","first-page":"7172","DOI":"10.1016\/j.biomaterials.2014.04.104","article-title":"Chitosan-modified porous silicon microparticles for enhanced permeability of insulin across intestinal cell monolayers","volume":"35","author":"Shrestha","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2016.04.024_bb0215","doi-asserted-by":"crossref","first-page":"9199","DOI":"10.1016\/j.biomaterials.2014.07.026","article-title":"The impact of nanoparticles on the mucosal translocation and transport of GLP-1 across the intestinal epithelium","volume":"35","author":"Araujo","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2016.04.024_bb0220","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.addr.2013.01.003","article-title":"In vitro and in vivo models for the study of oral delivery of nanoparticles","volume":"65","author":"Gamboa","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2016.04.024_bb0225","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1463-1326.2011.01473.x","article-title":"Dipeptidyl peptidase-4 inhibitors and preservation of pancreatic islet-cell function: a critical appraisal of the evidence","volume":"14","author":"van Genugten","year":"2012","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.jconrel.2016.04.024_bb0230","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1530\/eje.0.1460717","article-title":"Long-term inhibition of dipeptidyl peptidase IV improves glucose tolerance and preserves islet function in mice","volume":"146","author":"Reimer","year":"2002","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.jconrel.2016.04.024_bb0235","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.ejphar.2008.04.018","article-title":"Chronic administration of alogliptin, a novel, potent, and highly selective dipeptidyl peptidase-4 inhibitor, improves glycemic control and beta-cell function in obese diabetic ob\/ob mice","volume":"588","author":"Moritoh","year":"2008","journal-title":"Eur. J. Pharmacol."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365916302255?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365916302255?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T15:31:13Z","timestamp":1759159873000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365916302255"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":47,"alternative-id":["S0168365916302255"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2016.04.024","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oral hypoglycaemic effect of GLP-1 and DPP4 inhibitor based nanocomposites in a diabetic animal model","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2016.04.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}